Long-lasting expression of HO-1 delays progression of type I diabetes in NOD mice

Cell Cycle

Volumn 6, Issue 5, 2007, Pages 567-571

  Li, Ming ^a,b   Peterson, Stephen ^b   Husney, Daniel ^b   Inaba, Muneo ^a   Guo, Kequan ^a   Kappas, Attallah ^b,c   Ikehara, Susumu ^a   Abraham, Nader G ^b,c  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Carbon monoxide; Cobalt protoporphyrin IX dichloride; Dendritic cells; Heme oxygenase; Phosphorylated AKT; Reactive oxygen species; Superoxide anion; Type 1 diabetes

Indexed keywords

CARBON MONOXIDE; COBALT DERIVATIVE; GLUCAGON; HEME OXYGENASE 1; INSULIN; MESOPORPHYRIN TIN; PROTEIN BCL XL; PROTEIN KINASE B; PROTOPORPHYRIN; PROTOPORPHYRIN IX COBALT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DISEASE COURSE; DRUG MECHANISM; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SYNTHESIS; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PANCREAS; PANCREAS ISLET BETA CELL; PROTEIN EXPRESSION; T LYMPHOCYTE; UPREGULATION; WESTERN BLOTTING;

ANIMALIA; MUS;

EID: 33947326097     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.6.5.3917     Document Type: Article

References (33)

1. Verdaguer J, Amrani A, Anderson B, Schmidt D, Santamaria P. Two mechanisms for the non-MHC-linked resistance to spontaneous autoimmunity. J Immunol 1999; 162 4614-26.
2. Lesage S, Hartley SB, Akkaraju S, Wilson J, Townsend M, Goodnow CC. Failure to censor forbidden clones of CD4 T cells in autoimmune diabetes. J Exp Med 2002; 196:1175-88.
3. Kreuwel HT, Biggs JA, Pilip IM, Pamer EG, Lo D, Sherman LA. Defective CD8+ T cell peripheral tolerance in nonobese diabetic mice. J Immunol 2001; 167:1112-17.
4. Kishimoto H, Sprent J. A defect in central tolerance in NOD mice. Nat Immunol 2001; 2:1025-31.
5. Atkinson MA, Leiter EH. The NOD mouse model of type 1 diabetes: as good as it gets?, Nat Med 1999; 5:601-4.
6. Tay YC, Wang Y, Kairaitis L, Rangan GK, Zhang C, Harris DC. Can murine diabetic nephropathy be separated from superimposed acute renal failure? Kidney Int 2005; 68:391-98.
7. Kaneto H, Fujii J, Seo HG, Suzuki K, Matsuoka T, Nakamura M, Tatsumi H, Yamasaki Y, Kamada T, Taniguchi N. Apoptotic cell death triggered by nitric oxide in pancreatic β-cells. Diabetes 1995; 44:733-38.
8. Kurrer MO, Pakala SV, Hanson HL, Katz JD. B cell apoptosis in T cell-mediated autoimmune diabetes. Proc Natl Acad Sci USA 1997; 94:213-18.
9. O'Brien BA, Harmon BV, Cameron DP, Allan DJ. Apoptosis is the mode of β-cell death responsible for the development of IDDM in the nonobese diabetic (NOD) mouse. Diabetes 1997; 46:750-57.
10. Chervonsky AV, Wang Y, Wong FS, Visintin I, Flavell RA, Janeway CA, Jr., Matis LA. The role of Fas in autoimmune diabetes. Cell 1997; 89:17-24.
11. Itoh N, Imagawa A, Hanafusa T, Waguri M, Yamamoto K, Iwahashi H, Moriwaki M, Nakajima H, Miyagawa J, Namba M, Makino S, Nagata S, Kono N, Matsuzawa Y. Requirement of Fas for the development of autoimmune diabetes in nonobese diabetic mice, J Exp Med 1997; 186:613-18.
12. Rabinovitch A, Suarez WL, Thomas PD, Strynadka K, Simpson I. Cytotoxic effects of cytokines on rat islets: evidence for involvement of free radicals and lipid peroxidation, Diabetologia 1992; 35:409-13.
13. Abraham NG, Kappas A. Heme oxygenase and the cardiovascular-renal system. Free Radic Biol Med 2005; 39:1-25.
14. Choi BM, Pae HO, Jeong YR, Kim YM, Chung HT. Critical role of heme oxygenase-1 in Foxp3-mediated immune suppression. Biochem Biophys Res Commun 2005; 327:1066-71.
15. Pae HO, Oh GS, Choi BM, Chae SC, Kim YM, Chung KR, Chung HT. Carbon monoxide produced by heme oxygenase-1 suppresses T cell proliferation via inhibition of IL-2 production. J Immunol 2004; 172:4744-51.
16. Chen S, Kapturczak MH, Wasserfall C, Glushakova OY, Campbell-Thompson M, Deshane JS, Joseph R, Cruz PE, Hauswirth WW, Madsen KM, Croker BP, Berns KI, Atkinson MA, Flotte TR, Tisher CC. A. Agarwal, Interleukin 10 attenuates neointimal proliferation and inflammation in aortic allografts by a heme oxygenase-dependent pathway. Proc Natl Acad Sci USA 2005; 102:7251-56.
17. Chauveau C, Remy S, Royer PJ, Hill M, Tanguy-Royer S, Hubert FX, Tesson L, Brion R, Beriou G, Gregoire M, Josien R, Cuturi MC, Anegon I. Heme oxygenase-1 expression inhibits dendritic cell maturation and proinflammatory function but conserves IL-10 expression Blood 2005; 106:1694-1702.
18. Kruger AL, Peterson S, Turkseven S, Kaminski PM, Zhang FF, Quan S, Wolin MS, Abraham NG. D-4F induces heme oxygenase-1 and extracellular superoxide dismutase, decreases endothelial cell sloughing and improves vascular reactivity in rat model of diabetes, Circulation 2005; 23:3126-34.
19. Abraham NG, Kushida T, McClung J, Weiss M, Quan S, Lafaro R, Darzynkiewicz Z, Wolin M. Heme oxygenase-1 attenuates glucose-mediated cell growth arrest and apoptosis in human microvessel endothelial cells. Circ Res 2003; 93:507-14.
20. Pileggi A, Molano RD, Berney T, Cattan P, Vizzardelli C, Oliver R, Fraker C, Ricordi C, Pastori RL, Bach FH, Inverardi L. Heme oxygenase-1 induction in islet cells results in protection from apoptosis and improved in vivo function after transplantation. Diabetes 2001; 50:1983-91.
21. Ryter SW, Alam J, Choi AM. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev 2006; 86:583-650.
22. Ikehara S, Ohtsuki H, Good RA, Asamoto H, Nakamura T, Sekita K, Muso E, Tochino Y, Ida T, Kuzuya H. Prevention of type I diabetes in nonobese diabetic mice by allogenic bone marrow transplantation. Proc Natl Acad Sci USA 1985; 82:7743-47.
23. Ye J, Laychock SG. A protective role for heme oxygenase expression in pancreatic islets exposed to interleukin-1β. Endocrinology 1998; 139:4155-63.
24. Turkseven S, Kruger A, Mingone CJ, Kaminski P, Inaba M, Rodella L, Ikehara S, Wolin MS, Abraham NG. Antioxidant mechanism of heme oxygenase-1 involves an increase in superoxide dismutase and catalase in experimental diabetes. Am J Physiol Heart Circ Physiol 2005; 289:H701-H707.
25. Lenzen S, Drinkgern J, Tiedge M. Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radic Biol Med 1996; 20:463-66.
26. Kubisch HM, Wang J, Luche R, Carlson E, Bray TM, Epstein CJ, Phillips HP. Transgenic copper/zinc superoxide dismutase modulates susceptibility to type I diabetes. Proc Natl Acad Sci USA 1994; 91:9956-59.
27. Gottlob K, Majewski N, Kennedy S, Kandel E, Robey RB, Hay N. Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. Genes Dev 2001; 15:1406-18.
28. Di Noia MA, Van DS, Palmieri F, Yang LM, Quan S, Goodman AI, Abraham NG. Heme oxygenase-1 enhances renal mitochondrial transport carriers and cytochrome C oxidase activity in experimental diabetes. J Biol Chem 2006; 281:15687-93.
29. Dickson LM, Lingohr MK, McCuaig J, Hugl SR, Snow L, Kahn BB, Myers MG, Jr., Rhodes CJ. Differential activation of protein kinase B and p70(S6)K by glucose and insulin-like growth factor 1 in pancreatic β-cells (INS-1). J Biol Chem 2001; 276:21110-20.
30. Bernal-Mizrachi E, Wen W, Stahlhut S, Welling CM, Permutt MA. Islet β cell expression of constitutively active Akt1/PKB α induces striking hypertrophy, hyperplasia, and hyperinsulinemia. J Clin Invest 2001; 108:1631-38.
31. Tuttle RL, Gill NS, Pugh W, Lee JP, Koeberlein B, Furth EE, Polonsky KS, Naji A, Birnbaum MJ. Regulation of pancreatic β-cell growth and survival by the serine/threonine protein kinase Akt1/PKBα. Nat Med 2001; 7:1133-37.
32. Bernal-Mizrachi E, Fatrai S, Johnson JD, Ohsugi M, Otani K, Han Z, Polonsky KS, Permutt MA. Defective insulin secretion and increased susceptibility to experimental diabetes are induced by reduced Akt activity in pancreatic islet β cells. J Clin Invest 2004; 114:928-36.
33. Rao P, Roccisana J, Takane KK, Bottino R, Zhao A, Trucco M, Garcia-Ocana A. Gene transfer of constitutively active Akt markedly improves human islet transplant outcomes in diabetic severe combined immunodeficient mice. Diabetes 2005; 54:1664-75.